Neogen (NEOG) Property, Plant & Equipment (Net) Growth (3y) (2014 - 2026)
Neogen (NEOG) Property, Plant & Equipment (Net) Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 10.68% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 8.70% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 10.02% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 17.65% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 3.48% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 13.54% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 10.10% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -2.76% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 7.96% |
| 10 | Neogen | 2.61 Bn | 2.42 Bn | 107.80 Mn | 18.39% |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 18.39% |
| Feb 28, 2026 | 26.26% |
| Nov 30, 2025 | 30.90% |
| Aug 31, 2025 | 41.91% |
| May 31, 2025 | 45.28% |
| Feb 28, 2025 | 46.30% |
| Nov 30, 2024 | 45.48% |
| Aug 31, 2024 | 44.61% |
| May 31, 2024 | 40.25% |
| Feb 29, 2024 | 40.59% |
| Nov 30, 2023 | 42.87% |
| Aug 31, 2023 | 39.99% |
| May 31, 2023 | 36.20% |
| Feb 28, 2023 | 28.13% |
| Nov 30, 2022 | 24.30% |
| Aug 31, 2022 | 17.21% |
| May 31, 2022 | 13.90% |
| Feb 28, 2022 | 11.05% |
| Nov 30, 2021 | 10.92% |
| Aug 31, 2021 | 10.94% |